Cost-benefit determinations in screening mammography.
A cost-benefit analysis clearly shows that the costs for screening a large population of asymptomatic women are well within the cost-benefit range accepted for other areas within the medical care system. Reduction in cancer deaths is not easy to come by. When a method is available which can achieve this result, every effort should be made to make it available until it can be replaced satisfactorily with a less expensive, equally effective method.
D001943:Breast Neoplasms / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D005260:Female; D006801:Humans; D008327:Mammography / Q000191:economics*; D008403:Mass Screening / Q000191:economics*; D014481:United States